Drugscan

Name

Drugscan

Legal name

DRUGSCAN, Inc.

Website

https://drugscan.com

Company type

Private

Founded year

1985

Operating status

Operating

Headcount range

101–250 employees

Ownership category

akta.pro rank

Product category

Clinical Toxicology Laboratory Services

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Toxicology & Therapeutic Drug Monitoring Laboratories (HLAFAMAF)

akta.pro secondary industries

Drug & Alcohol Testing Coordination (BPACALAE), Pharmacovigilance, Medication Safety & Controlled Substance Diversion Monitoring (HLAFALAN)

Keywords

• Clinical toxicology testing
• Drug monitoring services
• Substance use disorder testing
• Workplace drug screening
• Reference laboratory services

Headquarters

HQ city

Horsham

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others

Revenue model

1. Clinical Laboratory Testing Services: Drug testing services including presumptive (screening) and definitive (confirmatory) tests billed using HCPCS codes (80307, G0480-G0483). Medicare payment based on established fee schedules with National Limitation Amounts.
2. Healthcare Operations Support: Laboratory testing provided to physicians and healthcare professionals for treatment purposes, with billing for services rendered

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

DRUGSCAN is a clinical toxicology laboratory providing drug and substance use disorder testing services. Its core offerings span presumptive (screening) and definitive (confirmatory) drug testing, prescription drug monitoring, substance use disorder management, workplace and law enforcement drug testing, and hospital/reference lab confirmation services. Testing is supported by reflex confirmation protocols using LCMSMS and GCMS, an extensive lab-developed test menu, online ordering and results portals, and direct access to PhD board-certified toxicologists.

Product overview

DRUGSCAN offers a unified toxicology and drug monitoring service portfolio centered on its core Drug Monitoring platform. The main offerings include Prescription Drug Monitoring, Substance Use Disorder Management, and Workplace Testing (with sub-services for Law Enforcement and Healthcare Professionals), all supported by Hospital and Reference Lab Services. Additional services like Virtual Specimen Collection and DOCTOX complement the testing workflow. As a CAP-accredited, SAMHSA-certified, and CLIA-licensed laboratory, the company delivers clinical excellence through confirmation testing, lab-developed tests, and toxicology expertise with time-saving technology tools.

Differentiator

Problem solved

Functional benefit

Brands

• DOCTOX: A specialized service offering for toxicology and drug monitoring.

Products and services

• Drug Monitoring Services Core toxicology and drug monitoring service providing tailored treatment plans and trusted testing for precise monitoring and actionable insights to support informed patient care for managing substance use disorders.
• Prescription Drug Monitoring
• Substance Use Disorder Management
• Workplace Testing and Monitoring
• Law Enforcement Testing
• Healthcare Professionals Testing
• Hospital and Reference Lab Services
• Virtual Specimen Collection
• DOCTOX

Quantifiable outcome

• Responsive toxicology enabling critical decision-making with speed, expertise and efficiency

Named customers5 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core.

• ACM Global LaboratoriescoreStrategic or Co-development PartnerACM Global Laboratories is listed as a DRUGSCAN affiliate, indicating a shared corporate family or strategic relationship within the laboratory services ecosystem. The relationship suggests coordinated operations and shared expertise in toxicology and laboratory services.
• DSI Medical Services, Inc.coreStrategic or Co-development PartnerDSI Medical Services, Inc. is listed as a DRUGSCAN affiliate, indicating a shared corporate family or strategic relationship. DSI Medical Services provides medical review officer services and is part of the ACM Global/DRUGSCAN network of laboratory affiliates.
• Rochester Regional HospitalcoreStrategic or Co-development PartnerRochester Regional Hospital is listed as a DRUGSCAN affiliate. This relationship provides a clinical connection and referral network for laboratory testing services within the Rochester Regional Health system.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Others

• DSI Medical Services: Medical Review Officer (MRO) services provider listed as a DRUGSCAN affiliate within the RRH family. Adjacent rather than directly competitive; enables DRUGSCAN's workplace and professional-monitoring offerings to be delivered as an end-to-end MRO-plus-lab bundle.
• ACM Global Laboratories: Listed as a DRUGSCAN affiliate within the Rochester Regional Health network. While not a direct competitor, the affiliation creates both operational coordination opportunities and potential channel conflict worth noting as an ecosystem peer.

Direct peers

• Aegis Sciences Corporation: Specialized clinical laboratory focused on toxicology, drug monitoring, and pain-management/substance-use disorder testing. Like DRUGSCAN, Aegis operates as a high-complexity specialty tox lab serving healthcare providers, employers, and the criminal justice system.
• Millennium Health: Specialty toxicology laboratory providing definitive drug and alcohol testing for clinicians treating substance use disorders and chronic pain. Closely comparable to DRUGSCAN in clinical positioning, assay menu (LCMSMS-based confirmations), and primary customer set.
• Dominion Diagnostics: Specialty laboratory focused on medication monitoring, substance use disorder, and pain management toxicology testing. Shares DRUGSCAN's niche in clinician-ordered UDT and offers a directly overlapping test menu and customer base.

Broad incumbents

• Quest Diagnostics: National full-service clinical laboratory offering routine testing alongside workplace drug toxicology and pain management panels. Competes with DRUGSCAN for hospital reference lab work and employer accounts but offers a much broader non-tox menu and national PSC footprint.
• Laboratory Corporation of America (LabCorp): Largest U.S. clinical laboratory network with broad routine testing and a substantial workplace and clinical toxicology offering (including via MedTox). Competes with DRUGSCAN across hospital, employer, and physician tox ordering.
• ARUP Laboratories: National academic reference laboratory offering esoteric testing including toxicology and TDM. Comparable to DRUGSCAN at the high-complexity reference lab tier, particularly for hospital overflow confirmatory testing.
• Mayo Clinic Laboratories: Reference laboratory arm of Mayo Clinic offering broad esoteric and specialty testing, including toxicology. Comparable as a Center-of-Excellence-style reference lab to which hospitals send complex toxicology confirmations.
• Sonic Healthcare: Global diagnostics provider with U.S. lab operations offering clinical and workplace toxicology. Overlaps with DRUGSCAN in the workplace and clinical drug-testing category as part of a much broader lab portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/drugscan_tox

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Drugscan